BioMed Realty Leads Technology/Science Peer Group in 2026 GRESB Rankings and Releases 2025 Sustainability Report Highlighting Progress Across the Portfolio

SAN DIEGO--(BUSINESS WIRE)--BioMed Realty, a Blackstone Real Estate portfolio company and the largest private operator of real estate for the life science and advanced technology industries, today announced 2026 Global Real Estate Sustainability Benchmark (GRESB) results for the portfolio it operates and published its 2025 Sustainability Report.

The report details how BioMed Realty integrates sustainability into the development and operation of its portfolio, with a focus on long-term performance, resilience and responsible stewardship. This work was also highlighted in the portfolio’s 2026 GRESB assessment. BioMed Realty is a portfolio company within Blackstone’s Core+ Life Sciences Real Estate strategy, which ranked first in its peer group and was named a GRESB Sector Leader in the Standing Investments Benchmark for the Technology/Science sector in the Americas. In addition, the Company earned 4-Star GRESB Ratings in both the Standing Investments and Development Benchmarks.

“Delivering mission-critical infrastructure to our tenants requires a long-term commitment to building performance, efficiency and resilience,” said Tim Schoen, CEO of BioMed Realty. “The progress detailed in the Sustainability Report, together with our strong GRESB performance, reflects how these considerations are woven into the way we constantly strive to improve our portfolio.”

“Sustainability is integrated into how we evaluate, develop and operate our buildings,” said Joanna Hilvert, Vice President, Environmental, Sustainability and Transaction Assurance at BioMed Realty. “We use data and building-level insights to identify opportunities to improve performance, strengthen resilience and support the sustainability goals and experience of our tenants and communities. Our 2026 GRESB results provide external recognition of the important work our teams are doing across the portfolio every day.”

The 2025 Sustainability Report highlights progress in several areas:

• Energy and renewables: Since 2016, BioMed Realty has invested over $26 million across 196 energy-efficiency projects, generating estimated annual savings of more than $4.6 million in total, and continues to expand onsite renewable energy.
• Resilience and decarbonization: BioMed Realty launched its Asset Resilience and Compliance (ARC) framework to support decarbonization planning, regulatory preparedness and asset resilience across its portfolio.
• Building health and performance: BioMed Realty achieved Fitwel Champion status, certified 13 additional buildings under Fitwel v2.1 in 2025 and submitted 43 buildings for Fitwel Scale Performance certification. More than 60 percent of the Company’s U.S. operating portfolio, as measured by square feet, was Fitwel certified as of December 31, 2025.
• Tenant and community impact: Thirty-nine BioMed Realty properties received a 2025 Kingsley Excellence Award and the Company hosted over 900 tenant and community events.

The report also features property-level initiatives, including expanded onsite solar capacity at Pacific Research Center and Gateway of Pacific in South San Francisco, expected to collectively generate more than six million kWh of electricity annually, and the fully leased development of 75 Broadway in Cambridge, Massachusetts, which is designed to achieve a 51 percent reduction in overall site energy compared with the 2023 Stretch Code baseline and incorporates 159 kW of onsite solar.

To read BioMed Realty’s 2025 Sustainability Report and learn more about the Company’s sustainability initiatives, visit: biomedrealty.com/stewardship.

About BioMed Realty

BioMed Realty is the largest private owner of life science and advanced technology real estate serving the innovation industries in the United States and the United Kingdom. BioMed Realty creates purpose-built environments for innovation, designed to accelerate impact, foster community and keep discovery moving. The Company owns and operates 18 million square feet of purpose-built lab and office space across the world’s top innovation hubs, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder and Cambridge, U.K. Throughout these markets, BioMed Realty prioritizes amenities and programming that encourage connection and collaboration among tenants and local communities alike. To learn more, visit https://www.biomedrealty.com.